Citi Pharma Limited (PSX:CPHL)
Pakistan
· Delayed Price · Currency is PKR 92.50
-1.71 (-1.82%)
At close: Apr 23, 2025
Citi Pharma Revenue
Citi Pharma had revenue of 3.53B PKR in the quarter ending December 31, 2024, with 7.92% growth. This brings the company's revenue in the last twelve months to 13.19B, up 8.11% year-over-year. In the fiscal year ending June 30, 2024, Citi Pharma had annual revenue of 12.41B with 0.10% growth.
Revenue (ttm)
13.19B
Revenue Growth
+8.11%
P/S Ratio
1.52
Revenue / Employee
25.42M
Employees
519
Market Cap
20.10B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| GlaxoSmithKline Pakistan | 61.19B |
| Abbott Laboratories (Pakistan) | 68.18B |
| AGP Limited | 25.03B |
| Highnoon Laboratories | 24.63B |
| The Searle Company | 28.80B |
| Shifa International Hospitals | 25.45B |
| Ferozsons Laboratories | 16.82B |
| Otsuka Pakistan | 3.69B |